Insider trades › Pfizer › Albert Bourla
Albert Bourla: Pfizer stock transactions
Albert Bourla (Chairman & CEO, Director at Pfizer) reported 1 transaction in PFE stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: BOURLA ALBERT.
$0open-market sales (0 shares)
$1.0Mopen-market purchases (38,000 shares)
2026-08-12most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 12, 2026 | Open-market purchase | 38,000 | $26.34 | $1.0M | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.